Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Tan Sheet

Executive Summary

OTC HIV tests inch closer; FDA investigates Plan B vending machine; Crest toothpaste brightens in one use; L’Oreal sues J&J, Merck for sunscreen patent infringement; more News In Brief.

You may also be interested in...



Plan B Sales Continue In University Vending Machine, Unlikely To Spread

FDA will not move to stop Plan B sales via vending machine at a college health clinic where the population is of a legal age to buy the product without a prescription. While the decision could open a door for a limited number of copycats, the landscape for nonprescription emergency contraception remains limited.

Plan B Sales Continue In University Vending Machine, Unlikely To Spread

FDA will not move to stop Plan B sales via vending machine at a college health clinic where the population is of a legal age to buy the product without a prescription. While the decision could open a door for a limited number of copycats, the landscape for nonprescription emergency contraception remains limited.

Plan B Sales Continue In University Vending Machine, Unlikely To Spread

FDA will not move to stop Plan B sales via vending machine at a college health clinic where the population is of a legal age to buy the product without a prescription. While the decision could open a door for a limited number of copycats, the landscape for nonprescription EC remains limited.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

GB140150

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel